The development of potent and selective bisarylmaleimide GSK3 inhibitors. - Engler TA; Malhotra S; Burkholder TP; Henry JR; Mendel D; Porter WJ; Furness K; Diefenbacher C; Marquart A; Reel JK; Li Y; Clayton J; et al. (Bioorganic & medicinal chemistry letters, 2005)